Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. Reduced monthly costs for uninsured patients still amount to around $500.

Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success.

Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed ...

Green card holders have been warned that they could have their eligibility to stay in the U.S. revoked if they support terrorism or violence.

BrightGene is pitting BGM0504 against tirzepatide, the rival GLP-1/GIP drug in Lilly’s Mounjaro and Zepbound, in a phase 2 obesity trial that is scheduled to wrap up next year.

Scholar Rock’s spinal muscular atrophy drug helped maintain muscle mass for patients taking Lilly’s obesity blockbuster Zepbound.